Neuroscience Research
Neuroscience is the study of the nervous system - one of the major mammalian systems responsible for sustaining life. The central nervous system (CNS) and peripheral nervous system (PNS) work in concert to coordinate basic functions such as moving and breathing, as well as 'higher order' functions including thought, speech and emotion.
Neuroscience Research Products Areas
- Stress and Anxiety Research (392)
- Nociception (957)
- Neurotransmission (892)
- Neuropeptides (43)
- Neural Development (795)
- Memory, Learning and Cognition (746)
- Blood-Brain Barrier (119)
- Stroke Research (665)
- Sleep Research (267)
- Schizophrenia Research (709)
- Parkinson's Disease Research (752)
- Huntington's Disease Research (465)
- Epilepsy Research (560)
- Depression Research (631)
- Alzheimer's Disease Research (399)
- Addiction Research (509)
- Multiple Sclerosis (419)
Products for Neuroscience Research - Page 201
- Cat.No. Product Name Information/Activity
-
BCC1098
PD98059
PD98059 is a potent and selective MEK inhibitor with an IC50 of 5 µM. PD98059 binds to the inactive form of MEK, thereby preventing the activation of MEK1 (IC50 of 2-7 µM) and MEK2 (IC50 of 50 µM) by upstream kinases. PD98059 is a ligand for the aryl hydrocarbon receptor (AHR), and suppresses TCDD binding (IC50 of 4 μM) and AHR transformation (IC50 of 1 μM). PD98059 also inhibits autophagy.
-
BCC1093
SB202190 (FHPI)
SB 202190 is a cell-permeable p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM.
-
BCC3663
SB 203580
SB 203580 (RWJ 64809) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. SB 203580 inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK2a/p38. SB 203580 does not disrupt JNK activity and is an autophagy and mitophagy activator.
-
BCC3981
SW033291
SW033291 is a potent and high-affinity inhibitor of 15-PGDH with a Ki of 0.1 nM. SW033291 increases prostaglandin PGE2 levels in bone marrow and other tissues. SW033291 also promotes tissue regeneration.
-
BCC2016
Troglitazone
Troglitazone is a PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine PPARγ receptor, respectively.
-
BCC8051
WH-4-023
WH-4-023 is a potent and selective dual Lck/Src inhibitor with IC50 of 2 nM/6 nM for Lck and Src kinase respectively; little inhibition on p38α and KDR.
-
BCC2466
Alexidine dihydrochloride
Alexidine dihydrochloride is an anticancer agent that targets a mitochondrial tyrosine phosphatase, PTPMT1, in mammalian cells and causes mitochondrial apoptosis. Alexidine dihydrochloride has antifungal and antibiofilm activity against a diverse range of fungal pathogens.
-
BCC2388
Mitomycin C
Rivaroxaban (BAY 59-7939) is a highly potent,selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM).
-
BCC7648
QS 11
ARFGAP1 inhibitor; modulates Wnt signaling pathway,QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor.
-
BCC4302
SR-3677
SR-3677 is a potent and selective ROCK-II inhibitor with an IC50 of ~3 nM.


